Becerra Takes The Helm At HHS; More Visibility On Administration’s Drug Pricing Priorities To Follow
Executive Summary
Becerra’s HHS has a new crop of former Capitol Hill staffers in its policy ranks who are well versed on legislation in the health care realm, including prescription drug pricing reform. That will help advance the Administration’s agenda.
You may also be interested in...
Flurry Of Drug Pricing Bills Offer US Congress Range Of Policy Options
If pharma got to choose, it would pick the bills that seek to discourage price increases instead of the ones that allow the government to negotiate drug prices or use international reference pricing. It is unclear whether any legislation will pass, but without a Republican majority in the Senate, the risk for industry has never been greater.
More Like Untouchable? US Medicare ‘Protected Classes’ Stay Protected – Again
A decision made more than 15 years ago by CMS to require drug insurance plans to cover all drugs for six specific diseases has proven impervious to change. But will the protected classes remain if Part D is reformed more broadly?
ACA Champion Becerra Confirmed As HHS Chief
The former Congressman and California attorney general was confirmed with only one GOP vote. He’ll be integral to managing the pandemic as well as implementing the ACA and reimbursement policy.